title: Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells.
abstract: The effect of IL-3 on hematopoiesis in long-term culture (LTC) was studied by cocultivating normal human marrow cells with human marrow fibroblast feeders engineered to constitutively produce IL-3 and by adding soluble IL-3 to LTC according to a variety of dose-time schedules. Feeders stably producing 7 ng/ml IL-3, or LTC to which 10 ng/ml IL-3 was added daily for 5 wk, but not once or twice weekly for the same time period, increased the output of mature nonadherent cells and progenitors from LTC as compared to control cultures. At the time of the weekly half-medium change, when primitive clonogenic progenitors in the adherent layer of standard LTC are quiescent, such cells were actively cycling in cultures containing a continuous source of an adequate dose of IL-3. In LTC, where the proportion of IL-3-producing cells in the feeder layer was diluted to 10% and no IL-3 was detectable in culture medium, primitive adherent layer progenitors were, nevertheless, maintained as a population of continuously proliferating cells. Thus, the presence of IL-3 in LTC can enhance the proliferation and differentiation of very early human hematopoietic cells, but the concentration, duration of exposure, and method of IL-3 presentation are important determinants of the ultimate effects observed.
authors.affiliation: Terry Fox Laboratory, British Columbia Cancer Agency, Department of Medicine, Pathology, and Medical Genetics, University of British Columbia, Vancouver, Canada.
authors.forename: T
authors.initials: T
authors.lastname: Otsuka
authors.forename: J D
authors.initials: JD
authors.lastname: Thacker
authors.forename: C J
authors.initials: CJ
authors.lastname: Eaves
authors.forename: D E
authors.initials: DE
authors.lastname: Hogge
mesh_terms: D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003470:Culture Media; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007377:Interleukin-3 / Q000096:biosynthesis / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D012190:Retroviridae / Q000235:genetics; D012995:Solubility
chemical_list: D003470:Culture Media; D007377:Interleukin-3; D011994:Recombinant Proteins